Cellular and plasma oxidative stress biomarkers are raised in adults with bronchiectasis

Clinical Nutrition

Volumn 32, Issue 1, 2013, Pages 112-117

  Olveira, Gabriel ^a,b   Olveira, Casilda ^a   Dorado, Antonio ^a   García Fuentes, Eduardo ^a,b   Rubio, Elehazara ^a,b   Tinahones, Francisco ^c,d   Soriguer, Federico ^a,b   Murri, Mora ^c,d  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Servicio Endocrinología y Nutrición Del Hospital Universitario Virgen de la Victoria   (Spain)

Author keywords

Bronchiectasis; Cystic fibrosis; Lipid peroxidation; Oxidative stress biomarkers

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; 8 ISOPROSTANE; BIOLOGICAL MARKER; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BLOOD ANALYSIS; BRONCHIECTASIS; CELL LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; LIPID PEROXIDATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MITOCHONDRIAL MEMBRANE POTENTIAL; MONOCYTE; NEUTROPHIL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; TOTAL ANTIOXIDANT CAPACITY;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; BRONCHIECTASIS; CATALASE; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DOWN-REGULATION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LEUKOCYTES; LIPID PEROXIDATION; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDES; SUPEROXIDE DISMUTASE; UP-REGULATION; YOUNG ADULT;

EID: 84872604959     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.06.002     Document Type: Article

References (30)

1. Vendrell M., de Gracia J., Olveira C., Martinez M.A., Giron R., Maiz L., et al. Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery. Arch Bronconeumol 2008, 44:629-640.
2. O'Donnell A.E. Bronchiectasis. Chest 2008, 134:815-823.
3. Martinez-Garcia M.A., Soler-Cataluna J.J., Perpina-Tordera M., Roman-Sanchez P., Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007, 132:1565-1572.
4. Giustarini D., Dalle-Donne I., Tsikas D., Rossi R. Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 2009, 46:241-281.
5. Cantin A.M., White T.B., Cross C.E., Forman H.J., Sokol R.J., Borowitz D. Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003. Free Radic Biol Med 2007, 42:15-31.
6. Fuschillo S., De Felice A., Balzano G. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J 2008, 31:396-406.
7. Loukides S., Bouros D., Papatheodorou G., Lachanis S., Panagou P., Siafakas N.M. Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 2002, 12:81-87.
8. Wood L.G., Garg M.L., Simpson J.L., Mori T.A., Croft K.D., Wark P.A., et al. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. Am J Respir Crit Care Med 2005, 171:426-430.
9. Wood L.G., Fitzgerald D.A., Gibson P.G., Cooper D.M., Collins C.E., Garg M.L. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001, 20:157-165.
10. Lagrange-Puget M., Durieu I., Ecochard R., Abbas-Chorfa F., Drai J., Steghens J.P., et al. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Pediatr Pulmonol 2004, 38:43-49.
11. Sagel S.D., Sontag M.K., Anthony M.M., Emmett P., Papas K.A. Effect of an antioxidant-rich multivitamin supplement in cystic fibrosis. J Cyst Fibros 2011, 10:31-36.
12. Mariggio M.A., Falone S., Morabito C., Guarnieri S., Mirabilio A., Pilla R., et al. Peripheral blood lymphocytes: a model for monitoring physiological adaptation to high altitude. High Alt Med Biol 2010, 1:333-342.
13. Naidich D.P., McCauley D.I., Khouri N.F., Stitik F.P., Siegelman S.S. Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982, 6:437-444.
14. Olveira G., Olveira C., Casado-Miranda E., Padilla A., Dorado A., Rojo-Martinez G., et al. Markers for the validation of reported dietary intake in adults with cystic fibrosis. J Am Diet Assoc 2009, 109:1704-1711.
15. Bhalla M., Turcios N., Aponte V., Jenkins M., Leitman B.S., McCauley D.I., et al. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991, 179:783-788.
16. Murri M., Garcia-Delgado R., Alcazar-Ramirez J., Linde F., Fernandez-Ramos A., Cardona F., et al. Assessment of cellular and plasma oxidative stress in SAHS patients before and after continuous positive airway pressure treatment. Clin Lab 2010, 56:397-406.
17. Garcia-Fuentes E., Murri M., Garrido-Sanchez L., Garcia-Serrano S., Garcia-Almeida J.M., Moreno-Santos I., et al. PPARgamma expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons. Obes (Silver Spring) 2010, 18:952-958.
18. Cantin A.M. Potential for antioxidant therapy of cystic fibrosis. Curr Opin Pulm Med 2004, 10:531-536.
19. Painter R.G., Valentine V.G., Lanson N.A., Leidal K., Zhang Q., Lombard G., et al. Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 2006, 45:10260-10269.
20. Lands L.C., Grey V., Smountas A.A., Kramer V.G., McKenna D. Lymphocyte glutathione levels in children with cystic fibrosis. Chest 1999, 116:201-205.
21. Grey V., Mohammed S.R., Smountas A.A., Bahlool R., Lands L.C. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros 2003, 2:195-198.
22. Kelly-Aubert M., Trudel S., Fritsch J., Nguyen-Khoa T., Baudouin-Legros M., Moriceau S., et al. GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models. Hum Mol Genet 2011, 20:2745-2759.
23. Olveira G., Olveira C. Nutrition, cystic fibrosis and the digestive tract. Nutr Hosp 2008, 23(Suppl. 2):71-86.
24. Madarasi A., Lugassi A., Greiner E., Holics K., Biro L., Mozsary E. Antioxidant status in patients with cystic fibrosis. Ann Nutr Metab 2000, 44:207-211.
25. Slobodianik N.H., Feliu M.S., Perris P., Barbeito S., Strasnoy I., Franchello A., et al. Inflammatory biomarker profile in children with cystic fibrosis: preliminary study. Proc Nutr Soc 2010, 69:354-356.
26. Sadowska-Woda I., Rachel M., Pazdan J., Bieszczad-Bedrejczuk E., Pawliszak K. Nutritional supplement attenuates selected oxidative stress markers in pediatric patients with cystic fibrosis. Nutr Res 2011, 31:509-518.
27. Lepage G., Champagne J., Ronco N., Lamarre A., Osberg I., Sokol R.J., et al. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1996, 64:87-93.
28. Rai R.R., Phadke M.S. Plasma oxidant-antioxidant status in different respiratory disorders. Indian J Clin Biochem 2006, 21:161-164.
29. Percival S.S., Bowser E., Wagner M. Reduced copper enzyme activities in blood cells of children with cystic fibrosis. Am J Clin Nutr 1995, 62:633-638.
30. Matkovics B., Gyurkovits K., Laszlo A., Szabo L. Altered peroxide metabolism in erythrocytes from children with cystic fibrosis. Clin Chim Acta 1982, 125:59-62.